机械介导的半可转换凝启用了持续的药物释放
Hongyue Jiang1, Xing Lu2,3, Tianshi Bu1
1State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.
Advanced healthcare materials
|May 22, 2025
概括
这项研究引入了一种新型的半可转换水凝,可以动态地应对机械应力,改善药物输送,促进伤口愈合. 该材料有效降低炎症,并在动态环境中促进组织再生.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 动态机械力阻碍伤口愈合,并加剧炎症和痕.
- 开发适用于动态环境的有效伤口治疗仍然是一个重大挑战.
研究的目的:
- 开发一种机械介导的半可转换水凝 (MechSCH),以增强动态伤口愈合.
- 研究超分子网络和聚合物网络之间的协同相互作用,以改善药物输送.
主要方法:
- 制造MechSCH利用超分子非共价网络和聚乙烯醇/凝聚合物网络之间的协同相互作用.
- 在剪切应力下水凝的凝-溶液过渡的表征 (≈9.04 Pa).
- 使用血小板衍生生长因子 (PDGF) 的小鼠背部全厚皮肤伤口模型中持续药物释放和治疗效果的评估.
主要成果:
- 在生理剪切压力下,MechSCH表现出了部分凝-溶液过渡,使得药物释放有反应性.
- 观察到PDGF从MechSCH持续释放,超过了非敏感的水凝.
- 在伤口模型中,发现炎症显著减少和血管再生加速.
结论:
- MechSCH通过提供持续的药物释放,有效地管理动态的伤口环境.
- 这种水凝在慢性伤口管理中显示出临床应用的希望.
- 机械介导的方法为促进机械应力下组织修复提供了一种新的策略.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Modified-Release Drug Delivery Systems: Drug Release Characteristics
263
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
263
Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
Modified-Release Drug Delivery Systems: Rate-Programmed I
174
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
174
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Oral Drug Delivery Systems: Continuous-Release Systems
319
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
319


